LLY
738.06
+1.61%↑
JNJ
178.12
-0.03%↓
ABBV
209.99
-1.09%↓
UNH
320.2
+1.63%↑
NVO
54.31
-1.47%↓
LLY
738.06
+1.61%↑
JNJ
178.12
-0.03%↓
ABBV
209.99
-1.09%↓
UNH
320.2
+1.63%↑
NVO
54.31
-1.47%↓
LLY
738.06
+1.61%↑
JNJ
178.12
-0.03%↓
ABBV
209.99
-1.09%↓
UNH
320.2
+1.63%↑
NVO
54.31
-1.47%↓
LLY
738.06
+1.61%↑
JNJ
178.12
-0.03%↓
ABBV
209.99
-1.09%↓
UNH
320.2
+1.63%↑
NVO
54.31
-1.47%↓
LLY
738.06
+1.61%↑
JNJ
178.12
-0.03%↓
ABBV
209.99
-1.09%↓
UNH
320.2
+1.63%↑
NVO
54.31
-1.47%↓
24h
Current
Min
9.85
Max
10.51
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +99.81% upside |
Next Earnings | 10 lis 2025 |
---|
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
27 lis 2024, 13:34 UTC
CervoMed Shares Rise 15% on FDA's Orphan Drug Designation for Neflamapimod
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 21 USD 99.81%
High 31 USD
Low 11 USD
Based on 5 Wall Street analysts offering 12 month price targets forCervoMed Inc - Dist in the last 3 months.
By TipRanks
Strong Buy
5 ratings
4
Buy
1
Hold
0
Sell
Based on 5 analysts giving stock ratings to CervoMed Inc - Dist in the past 3 months.
$